180 related articles for article (PubMed ID: 38183609)
1. FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease.
Li L; Kong L; Xu S; Wang C; Gu J; Luo H; Meng Q
Hepatol Int; 2024 Feb; 18(1):188-205. PubMed ID: 38183609
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease.
Xu S; Kong L; Li L; Wang C; Gu J; Luo H; Meng Q
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166930. PubMed ID: 37918680
[TBL] [Abstract][Full Text] [Related]
3. Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR.
Li L; Xu S; Wang W; Li X; Wang H; Yang Q; Wang C; Gu J; Luo H; Meng Q
Phytomedicine; 2024 May; 130():155693. PubMed ID: 38763006
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation.
Wang Y; Chen C; Chen J; Sang T; Peng H; Lin X; Zhao Q; Chen S; Eling T; Wang X
Redox Biol; 2022 Jun; 52():102322. PubMed ID: 35504134
[TBL] [Abstract][Full Text] [Related]
5. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
[TBL] [Abstract][Full Text] [Related]
6. Altered ethanol metabolism and increased oxidative stress enhance alcohol-associated liver injury in farnesoid X receptor-deficient mice.
Morel C; Chowdhary V; Thevkar Nagesh P; Ribeiro M; Hawryluk D; Catalano D; Adorini L; Szabo G
Liver Int; 2023 Jan; 43(1):100-114. PubMed ID: 35869657
[TBL] [Abstract][Full Text] [Related]
7. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
[TBL] [Abstract][Full Text] [Related]
8. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
Lu C; Zhang F; Xu W; Wu X; Lian N; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
IUBMB Life; 2015 Aug; 67(8):645-58. PubMed ID: 26305715
[TBL] [Abstract][Full Text] [Related]
9. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
[TBL] [Abstract][Full Text] [Related]
10. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
[TBL] [Abstract][Full Text] [Related]
11. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
[TBL] [Abstract][Full Text] [Related]
12. Total saponins from Panax japonicus attenuate acute alcoholic liver oxidative stress and hepatosteatosis by p62-related Nrf2 pathway and AMPK-ACC/PPARα axis in vivo and in vitro.
Qiu L; Feng R; Wu QS; Wan JB; Zhang QW
J Ethnopharmacol; 2023 Dec; 317():116785. PubMed ID: 37321425
[TBL] [Abstract][Full Text] [Related]
13. The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in mice.
Lívero FA; Stolf AM; Dreifuss AA; Bastos-Pereira AL; Chicorski R; de Oliveira LG; de Souza CE; Fabossi IA; Rabitto IS; Gremski LH; Henneberg R; Telles JE; Oude Elferink RP; Acco A
Chem Biol Interact; 2014 Jun; 217():19-27. PubMed ID: 24713361
[TBL] [Abstract][Full Text] [Related]
14. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
[TBL] [Abstract][Full Text] [Related]
15. FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice.
Iracheta-Vellve A; Calenda CD; Petrasek J; Ambade A; Kodys K; Adorini L; Szabo G
Hepatol Commun; 2018 Nov; 2(11):1379-1391. PubMed ID: 30411084
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner.
Xu W; Lu C; Yao L; Zhang F; Shao J; Zheng S
Toxicol Appl Pharmacol; 2017 Jan; 315():23-34. PubMed ID: 27939985
[TBL] [Abstract][Full Text] [Related]
17. A combination of Pueraria lobata and Silybum marianum protects against alcoholic liver disease in mice.
Feng R; Chen JH; Liu CH; Xia FB; Xiao Z; Zhang X; Wan JB
Phytomedicine; 2019 May; 58():152824. PubMed ID: 30836218
[TBL] [Abstract][Full Text] [Related]
18. Chalcone Derivative L6H21 Reduces EtOH + LPS-Induced Liver Injury Through Inhibition of NLRP3 Inflammasome Activation.
Kong X; Wu G; Chen S; Zhang L; Li F; Shao T; Ren L; Chen SY; Zhang H; McClain CJ; Feng W
Alcohol Clin Exp Res; 2019 Aug; 43(8):1662-1671. PubMed ID: 31162673
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
Satishchandran A; Ambade A; Rao S; Hsueh YC; Iracheta-Vellve A; Tornai D; Lowe P; Gyongyosi B; Li J; Catalano D; Zhong L; Kodys K; Xie J; Bala S; Gao G; Szabo G
Gastroenterology; 2018 Jan; 154(1):238-252.e7. PubMed ID: 28987423
[TBL] [Abstract][Full Text] [Related]
20. FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice.
Zhang M; Kong B; Huang M; Wan R; Armstrong LE; Schumacher JD; Rizzolo D; Chow MD; Lee YH; Guo GL
Dig Liver Dis; 2018 Oct; 50(10):1068-1075. PubMed ID: 29730159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
